Insider · CIK 0001824542
Oxana Beskrovnaya
Files at DYN (Dyne Therapeutics, Inc.). First filing Dec 12, 2023, latest Mar 13, 2025.
In brief
Oxana Beskrovnaya files SEC Form 4 as officer at DYN (Dyne Therapeutics, Inc.). Since Dec 12, 2023, Oxana Beskrovnaya has reported 0 open-market buys worth $0 and 6 open-market sells worth $236k, the latest filed on Mar 13, 2025.
A track record needs three past buys with six months of prices behind them; Oxana Beskrovnaya has 0, so none is measured yet.
The newest scored trade: sold $25k of DYN on Mar 11, 2025, filed Mar 13, 2025, scored 10 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DYN: Dyne Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Dyne Therapeutics, Inc. | $25k 2,153 shares | -1% | - | |
| 10Weak | Dyne Therapeutics, Inc. | $13k 1,094 shares | -1% | - | |
| 9Weak | Dyne Therapeutics, Inc. | $36k 2,598 shares | -1% | - | |
| 18Weak | Dyne Therapeutics, Inc. | $66k 2,334 shares | -1% | - | |
| 19Weak | Dyne Therapeutics, Inc. | $81k 2,856 shares | -2% | - | |
| 10Weak | Dyne Therapeutics, Inc. | $16k 1,467 shares | -1% | +65% from low-27% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 11, 2025 | DYN Dyne Therapeutics, Inc. | 2,132 0.00% of outstanding | $31k | Jun 11, 2025 | $70k |
| Jun 5, 2025 | DYN Dyne Therapeutics, Inc. | 1,093 0.00% of outstanding | $15k | Jun 5, 2025 | $56k |
| May 16, 2025 | DYN Dyne Therapeutics, Inc. | 2,589 0.00% of outstanding | $31k | May 16, 2025 | $74k |
| Mar 11, 2025 | DYN Dyne Therapeutics, Inc. | 2,153 0.00% of outstanding | $24k | Mar 11, 2025 | $115k |
| Mar 5, 2025 | DYN Dyne Therapeutics, Inc. | 1,094 0.00% of outstanding | $13k | Mar 5, 2025 | $102k |
| Feb 18, 2025 | DYN Dyne Therapeutics, Inc. | 2,598 0.00% of outstanding | $36k | Feb 18, 2025 | $66k |
| Dec 11, 2024 | DYN Dyne Therapeutics, Inc. | 2,334 0.00% of outstanding | $66k | Dec 11, 2024 | $299k |
| Nov 18, 2024 | DYN Dyne Therapeutics, Inc. | 2,856 0.00% of outstanding | $81k | Nov 18, 2024 | $219k |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,153 | $11.38 | $25k | 195,840 | Mar 13, 2025 |
| Mar 5, 2025 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,094 | $11.83 | $13k | 197,993 | Mar 7, 2025 |
| Feb 18, 2025 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,598 | $13.95 | $36k | 199,087 | Feb 25, 2025 |
| Dec 11, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,334 | $28.12 | $66k | 201,685 | Dec 11, 2024 |
| Dec 4, 2024 | DYN Dyne Therapeutics, Inc. | AGrant or award Common Stock | +39,100 | $0.00 | $0 | 176,619 | Dec 6, 2024 |
| Dec 4, 2024 | DYN Dyne Therapeutics, Inc. | AGrant or award Common Stock | +27,400 | $0.00 | $0 | 204,019 | Dec 6, 2024 |
| Dec 4, 2024 | DYN Dyne Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +62,400 | $0.00 | $0 | 62,400 | Dec 6, 2024 |
| Nov 18, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,856 | $28.20 | $81k | 137,519 | Nov 18, 2024 |
| Dec 11, 2023 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,467 | $10.72 | $16k | 176,585 | Dec 12, 2023 |
| Nov 15, 2023 | DYN Dyne Therapeutics, Inc. | AGrant or award Common Stock | +93,718 | $0.00 | $0 | 178,052 | Nov 16, 2023 |
| Nov 15, 2023 | DYN Dyne Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +36,495 | $0.00 | $0 | 36,495 | Nov 16, 2023 |
Questions about Oxana Beskrovnaya
Answered from the filings on this page, as of the latest one.
Is Oxana Beskrovnaya buying or selling?
Not in the last 12 months. Oxana Beskrovnaya's latest open-market trade on SEC Form 4 was sold $25k of DYN on Mar 11, 2025.
How did Oxana Beskrovnaya's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Oxana Beskrovnaya has 0.
Where does Oxana Beskrovnaya file Form 4?
Oxana Beskrovnaya has filed Form 4 at DYN (Dyne Therapeutics, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.